Assessment of rectal and urinary toxicity from the RADAR prostate radiotherapy trial – dosimetric constraints for novel symptom clustering, derivation of radiobiological parameters and assessment of patient localisation effects

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Increasing prostate radiotherapy cure rates by increasing radiation dose is limited by side-effects in the rectum and bladder which can greatly decrease patient quality of life. This study will utilise detailed data, collected during a large Australasian trial, to extract information on how patterns of dose delivery influence side-effects in the bladder and rectum, including a novel definition of rectal toxicity. The result will be more effective future treatment.

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2015

Funding Scheme: Project Grants

Funding Amount: $323,484.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Radiation Therapy

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

data analysis | modelling | morbidity | prostate cancer | quality of life | radiotherapy | statistics | toxicity